# Bionano Genomics Inc. (BNGO)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $6M  
**Price:** $1.16

> Bionano Genomics develops genome analysis software that enables genomics laboratories to analyze and interpret genomic data across multiple platforms, generating comprehensive insights for research and clinical applications. The company's solutions are designed to detect genomic variations and provide a unified view of genome data, addressing critical questions in cancer diagnosis, genetic disease detection, and treatment planning. Bionano Genomics serves the genomics and clinical laboratory markets, offering tools that integrate data from various sequencing and analysis technologies. The company operates in the life sciences and healthcare technology sector, where it plays a role in advancing precision medicine and improving diagnostic capabilities for healthcare providers and research institutions worldwide.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $29M | $13M | -$33M | -$26M | — |
| 2024 | $31M | $380,000 | -$104M | -$112M | — |
| 2023 | $36M | $10M | -$215M | -$232M | — |
| 2022 | $28M | $6M | -$132M | -$133M | — |
| 2021 | $18M | $4M | -$77M | -$72M | — |
| 2020 | $9M | $3M | -$39M | -$41M | — |
| 2019 | $10M | $3M | -$26M | -$30M | — |
| 2018 | $12M | $3M | -$20M | -$18M | — |
| 2017 | $10M | $3M | -$23M | -$23M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $74M | $29M | $44M | $3M | — |
| 2024 | $77M | $41M | $35M | $9M | — |
| 2023 | $214M | $118M | $96M | $18M | — |
| 2022 | $308M | $58M | $249M | $5M | — |
| 2021 | $377M | $40M | $337M | $25M | — |
| 2020 | $60M | $25M | $35M | $38M | $16M |
| 2019 | $30M | $27M | $4M | $17M | $20M |
| 2018 | $25M | $15M | $10M | $17M | $9M |
| 2017 | $10M | $17M | -$50M | $1M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$16M | — | — |
| 2024 | -$69M | — | — |
| 2023 | -$125M | — | — |
| 2022 | -$125M | — | — |
| 2021 | -$72M | — | — |
| 2020 | -$38M | — | -$38M |
| 2019 | -$30M | $61,056 | -$30M |
| 2018 | -$20M | $331,716 | -$20M |
| 2017 | -$21M | $1M | -$22M |

Source: [CompaniesByCap](https://companiesbycap.com/company/BNGO)